Related Experiment Video
Updated: May 23, 2026
06:51
Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome
Published on: July 28, 2023
Necrotizing enterocolitis risk: state of the science
Sheila M Gephart1, Jacqueline M McGrath, Judith A Effken
1College of Nursing, University of Arizona, Tucson, 85721, USA. sgephart@nursing.arizona.edu
Summary
Necrotizing enterocolitis (NEC) is a critical condition affecting premature infants in the NICU. Understanding NEC risk factors and implementing preventive strategies like human milk feeding can significantly reduce its incidence.
Area of Science:
- Neonatal intensive care
- Gastrointestinal diseases
- Pediatric surgery
Background:
- Necrotizing enterocolitis (NEC) is a leading cause of death and illness in neonatal intensive care units (NICUs).
- Premature infants are most susceptible to NEC, a condition that incurs substantial healthcare costs.
- Surgical NEC survivors face prolonged NICU stays, impacting long-term outcomes.
Purpose of the Study:
- To review current scientific knowledge on NEC risk factors.
- To provide evidence-based recommendations for clinical practice and future research.
Main Methods:
- Literature review of scientific studies on NEC.
- Analysis of identified risk factors and preventive measures.
Main Results:
- Prematurity and formula feeding are consistent independent predictors of NEC.
- Combined risk factors can increase NEC incidence.
- Human milk feeding, feeding guidelines, and probiotics are effective in reducing NEC.
Conclusions:
- Awareness and management of NEC risk factors are crucial.
- Implementing preventive strategies can decrease NEC rates in vulnerable infants.
- Further research is needed to refine NEC prevention and treatment protocols.
Related Concept Videos
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:07Intestinal Obstruction II: Pathophysiology
Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD: